hrcak mascot   Srce   HID

Acta Pharmaceutica, Vol.65 No.2 Lipanj 2015.

Pregledni rad
https://doi.org/10.1515/acph-2015-0019

Virosome, a hybrid vehicle for efficient and safe drug delivery and its emerging application in cancer treatment

HANQING LIU ; School of Pharmacy, Jiangsu University, Zhenjiang, Jiangsu 212013, China
ZHIGANG TU ; Institute of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu 212013, China
FAN FENG ; Institute of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu 212013, China
HAIFENG SHI ; Institute of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu 212013, China
KEPING CHEN ; Institute of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu 212013, China
XIMING XU ; School of Pharmacy, Jiangsu University, Zhenjiang, Jiangsu 212013, China

Puni tekst: engleski, pdf (471 KB) str. 105-116 preuzimanja: 427* citiraj
APA 6th Edition
LIU, H., TU, Z., FENG, F., SHI, H., CHEN, K. i XU, X. (2015). Virosome, a hybrid vehicle for efficient and safe drug delivery and its emerging application in cancer treatment. Acta Pharmaceutica, 65 (2), 105-116. https://doi.org/10.1515/acph-2015-0019
MLA 8th Edition
LIU, HANQING, et al. "Virosome, a hybrid vehicle for efficient and safe drug delivery and its emerging application in cancer treatment." Acta Pharmaceutica, vol. 65, br. 2, 2015, str. 105-116. https://doi.org/10.1515/acph-2015-0019. Citirano 16.11.2018.
Chicago 17th Edition
LIU, HANQING, ZHIGANG TU, FAN FENG, HAIFENG SHI, KEPING CHEN i XIMING XU. "Virosome, a hybrid vehicle for efficient and safe drug delivery and its emerging application in cancer treatment." Acta Pharmaceutica 65, br. 2 (2015): 105-116. https://doi.org/10.1515/acph-2015-0019
Harvard
LIU, H., et al. (2015). 'Virosome, a hybrid vehicle for efficient and safe drug delivery and its emerging application in cancer treatment', Acta Pharmaceutica, 65(2), str. 105-116. doi: https://doi.org/10.1515/acph-2015-0019
Vancouver
LIU H, TU Z, FENG F, SHI H, CHEN K, XU X. Virosome, a hybrid vehicle for efficient and safe drug delivery and its emerging application in cancer treatment. Acta Pharm. [Internet]. 2015 [pristupljeno 16.11.2018.];65(2):105-116. doi: https://doi.org/10.1515/acph-2015-0019
IEEE
H. LIU, Z. TU, F. FENG, H. SHI, K. CHEN i X. XU, "Virosome, a hybrid vehicle for efficient and safe drug delivery and its emerging application in cancer treatment", Acta Pharmaceutica, vol.65, br. 2, str. 105-116, 2015. [Online]. doi: https://doi.org/10.1515/acph-2015-0019

Sažetak
A virosome is an innovative hybrid drug delivery system with advantages of both viral and non-viral vectors. Studies have shown that a virosome can carry various biologically active molecules, such as nucleic acids, peptides, proteins and small organic molecules. Targeted drug delivery using virosome-based systems can be achieved through surface modifications of virosomes. A number of virosome-based prophylactic and therapeutic products with high safety profiles are currently available in the market. Cancer treatment is a big battlefield for virosome-based drug delivery systems. This review provides an overview of the general concept, preparation procedures, working mechanisms, preclinical studies and clinical applications of virosomes in cancer treatment.

Ključne riječi
virosome; drug delivery system; cancer treatment; cancer vaccine

Hrčak ID: 128998

URI
https://hrcak.srce.hr/128998

Posjeta: 697 *